ProductsIsraeli Entrepreneurs’ Terpenes Plans For UK

Israeli Entrepreneurs’ Terpenes Plans For UK

-

TWO Israeli businessmen with strong UK links have joined forces to deliver high-quality cannabis terpenes to European consumers.

CiiTech, a leading cannabis business, has partnered with Kanabo Research to launch terpene formulas for use with the latter’s VapePod.

In a press release the partners say they will use CiiTech’s ‘terpene formulas to meet the highest standards required for the UK market’.

These have been designed specifically for use with the VapePod, Kanabo’s patented device which was the first to be approved for medical use by the Israeli Ministry of Health. 

Terpenes are essential plant oils that deliver distinctive flavors and smells and include the likes of linalool – also present in lavender –  and pinene, in conifers.

They also confer therapeutic effects, with cannabis terpenes being used to promote sleep, fight inflammation and boost mood.

CiiTech was was founded by Clifton Flack, once of  iCAN and the investment platform CannaTech. 

The London-based company initiates in-house research and created Provocan which has been selected as best in class among UK CBD brands.

He said trust in CBD brands is ‘crucial’ and collaboration with partners such as Kanabo can help achieve that.

He added: “There’s a real growth in consumer understanding of the terpenes. 

“We believe our proven formulas created with Kanabo for the VapePod device deliver an exceptional level of CBD innovation and efficacy not previously seen in the industry.”

Kanabo plans to list on the London Stock Exchange in what will be an effective reverse takeover with UK shell company Spinnaker Opportunities PLC.


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Czech President Expected To Sign-Off Bill To Introduce ‘Technical Cannabis’ With A THC limit of 1.0%

SWEEPING changes to the way cannabis is regulated in the Czech Republic have been warmly welcomed as a positive...

Why Synthetic Cannabinoids Should Be The Chosen Path For The European Cannabis Industry

Precision-fermented cannabinoids are likely to disrupt Europe’s emerging medicinal and recreational cannabis-farming industry over the next few years -...

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further signs the UK’s National Health Service is warming to cannabis...

Reakiro – Europe’s Leading CBD And Hemp Brand – Delivers The Complete B2B & B2C Package

IN a time when CBD products are becoming unavoidable in the health, wellness and fitness industries, it is more...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European country to legalise adult-use cannabis have emerged. In an interview on...

Cannabis Is Now A Compelling Opportunity For The Main Tobacco Companies

International cannabis expert, Barbara Pastori, of Prohibition Partners shares her thoughts on why cannabis is a compelling opportunity for...

Must read

Czech President Expected To Sign-Off Bill To Introduce ‘Technical Cannabis’ With A THC limit of 1.0%

SWEEPING changes to the way cannabis is regulated in...

Why Synthetic Cannabinoids Should Be The Chosen Path For The European Cannabis Industry

Precision-fermented cannabinoids are likely to disrupt Europe’s emerging medicinal...

You might also likeRELATED
Recommended to you